Clinical Trial Update: Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total neoadjuvant therapy combined with tislelizumab for locally advanced rectal cancer; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN